nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0674	0.264	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0651	0.255	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.063	0.247	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0595	0.233	CiPCiCtD
Betamethasone—brain cancer—Triamcinolone—hematologic cancer	0.0514	0.337	CpDpCtD
Betamethasone—Dexamethasone—hematologic cancer	0.0473	0.263	CrCtD
Betamethasone—Triamcinolone—hematologic cancer	0.0462	0.256	CrCtD
Betamethasone—Prednisone—hematologic cancer	0.0438	0.243	CrCtD
Betamethasone—Prednisolone—hematologic cancer	0.0428	0.238	CrCtD
Betamethasone—NR3C1—hematologic cancer	0.042	0.675	CbGaD
Betamethasone—colon cancer—Dexamethasone—hematologic cancer	0.028	0.183	CpDpCtD
Betamethasone—brain cancer—Dexamethasone—hematologic cancer	0.028	0.183	CpDpCtD
Betamethasone—ABCB1—hematologic cancer	0.0203	0.326	CbGaD
Betamethasone—kidney cancer—Dexamethasone—hematologic cancer	0.0202	0.133	CpDpCtD
Betamethasone—PLA2G1B—Dexamethasone—hematologic cancer	0.0164	0.132	CbGbCtD
Betamethasone—prostate cancer—Dexamethasone—hematologic cancer	0.0146	0.0959	CpDpCtD
Betamethasone—NR3C2—Prednisolone—hematologic cancer	0.0124	0.0999	CbGbCtD
Betamethasone—breast cancer—Dexamethasone—hematologic cancer	0.0103	0.0673	CpDpCtD
Betamethasone—PTGS2—Lenalidomide—hematologic cancer	0.00918	0.0742	CbGbCtD
Betamethasone—NR3C2—Dexamethasone—hematologic cancer	0.00729	0.0589	CbGbCtD
Betamethasone—PTGS2—Thalidomide—hematologic cancer	0.0049	0.0396	CbGbCtD
Betamethasone—NR3C1—Triamcinolone—hematologic cancer	0.00482	0.0389	CbGbCtD
Betamethasone—PGR—Dexamethasone—hematologic cancer	0.00471	0.038	CbGbCtD
Betamethasone—NR3C1—Prednisolone—hematologic cancer	0.00408	0.033	CbGbCtD
Betamethasone—NR3C1—Prednisone—hematologic cancer	0.00385	0.0311	CbGbCtD
Betamethasone—PTGS2—Triamcinolone—hematologic cancer	0.0034	0.0275	CbGbCtD
Betamethasone—ABCB1—Lenalidomide—hematologic cancer	0.00303	0.0245	CbGbCtD
Betamethasone—CYP19A1—Dexamethasone—hematologic cancer	0.00265	0.0214	CbGbCtD
Betamethasone—PGR—ovarian follicle—hematologic cancer	0.00249	0.197	CbGeAlD
Betamethasone—NR3C1—Dexamethasone—hematologic cancer	0.0024	0.0194	CbGbCtD
Betamethasone—CYP19A1—ovarian follicle—hematologic cancer	0.00224	0.177	CbGeAlD
Betamethasone—PTGS2—Cisplatin—hematologic cancer	0.0021	0.017	CbGbCtD
Betamethasone—PTGS2—Etoposide—hematologic cancer	0.00206	0.0167	CbGbCtD
Betamethasone—CYP3A4—Bexarotene—hematologic cancer	0.00182	0.0147	CbGbCtD
Betamethasone—ABCB1—Daunorubicin—hematologic cancer	0.00178	0.0144	CbGbCtD
Betamethasone—ABCB1—Alitretinoin—hematologic cancer	0.00174	0.0141	CbGbCtD
Betamethasone—PTGS2—Dexamethasone—hematologic cancer	0.0017	0.0137	CbGbCtD
Betamethasone—CYP3A4—Busulfan—hematologic cancer	0.00169	0.0136	CbGbCtD
Betamethasone—CYP3A4—Lomustine—hematologic cancer	0.00169	0.0136	CbGbCtD
Betamethasone—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00161	0.0119	CrCrCtD
Betamethasone—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00157	0.0116	CrCrCtD
Betamethasone—CYP3A4—Thiotepa—hematologic cancer	0.0015	0.0122	CbGbCtD
Betamethasone—Flurandrenolide—Dexamethasone—hematologic cancer	0.0015	0.0111	CrCrCtD
Betamethasone—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00145	0.0107	CrCrCtD
Betamethasone—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00141	0.0105	CrCrCtD
Betamethasone—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.0014	0.0104	CrCrCtD
Betamethasone—Difluprednate—Dexamethasone—hematologic cancer	0.0014	0.0104	CrCrCtD
Betamethasone—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.0014	0.0104	CrCrCtD
Betamethasone—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00137	0.0101	CrCrCtD
Betamethasone—Difluprednate—Triamcinolone—hematologic cancer	0.00137	0.0101	CrCrCtD
Betamethasone—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00137	0.0101	CrCrCtD
Betamethasone—ABCB1—Imatinib—hematologic cancer	0.00136	0.011	CbGbCtD
Betamethasone—Flurandrenolide—Prednisolone—hematologic cancer	0.00136	0.01	CrCrCtD
Betamethasone—Testolactone—Dexamethasone—hematologic cancer	0.00132	0.00974	CrCrCtD
Betamethasone—Clocortolone—Dexamethasone—hematologic cancer	0.00132	0.00974	CrCrCtD
Betamethasone—Beclomethasone—Dexamethasone—hematologic cancer	0.00132	0.00974	CrCrCtD
Betamethasone—Fluocinonide—Dexamethasone—hematologic cancer	0.00132	0.00974	CrCrCtD
Betamethasone—Prednicarbate—Dexamethasone—hematologic cancer	0.00132	0.00974	CrCrCtD
Betamethasone—Prednicarbate—Triamcinolone—hematologic cancer	0.00129	0.00952	CrCrCtD
Betamethasone—Fluocinonide—Triamcinolone—hematologic cancer	0.00129	0.00952	CrCrCtD
Betamethasone—Beclomethasone—Triamcinolone—hematologic cancer	0.00129	0.00952	CrCrCtD
Betamethasone—Clocortolone—Triamcinolone—hematologic cancer	0.00129	0.00952	CrCrCtD
Betamethasone—Testolactone—Triamcinolone—hematologic cancer	0.00129	0.00952	CrCrCtD
Betamethasone—Fluocortolone—Dexamethasone—hematologic cancer	0.00128	0.00946	CrCrCtD
Betamethasone—Fluocortolone—Triamcinolone—hematologic cancer	0.00125	0.00924	CrCrCtD
Betamethasone—PTGS2—ovarian follicle—hematologic cancer	0.00124	0.0985	CbGeAlD
Betamethasone—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00124	0.0092	CrCrCtD
Betamethasone—Alclometasone—Dexamethasone—hematologic cancer	0.00124	0.0092	CrCrCtD
Betamethasone—ABCB1—Nilotinib—hematologic cancer	0.00124	0.01	CbGbCtD
Betamethasone—ABCB1—Vinorelbine—hematologic cancer	0.00123	0.00991	CbGbCtD
Betamethasone—Testolactone—Prednisone—hematologic cancer	0.00122	0.00903	CrCrCtD
Betamethasone—Prednicarbate—Prednisone—hematologic cancer	0.00122	0.00903	CrCrCtD
Betamethasone—Alclometasone—Triamcinolone—hematologic cancer	0.00122	0.00899	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00122	0.00899	CrCrCtD
Betamethasone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00121	0.00895	CrCrCtD
Betamethasone—Amcinonide—Dexamethasone—hematologic cancer	0.00121	0.00895	CrCrCtD
Betamethasone—Budesonide—Dexamethasone—hematologic cancer	0.00121	0.00895	CrCrCtD
Betamethasone—Prednicarbate—Prednisolone—hematologic cancer	0.00119	0.00882	CrCrCtD
Betamethasone—Testolactone—Prednisolone—hematologic cancer	0.00119	0.00882	CrCrCtD
Betamethasone—Clocortolone—Prednisolone—hematologic cancer	0.00119	0.00882	CrCrCtD
Betamethasone—Beclomethasone—Prednisolone—hematologic cancer	0.00119	0.00882	CrCrCtD
Betamethasone—Fluocortolone—Prednisone—hematologic cancer	0.00119	0.00877	CrCrCtD
Betamethasone—Amcinonide—Triamcinolone—hematologic cancer	0.00118	0.00875	CrCrCtD
Betamethasone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00118	0.00875	CrCrCtD
Betamethasone—Budesonide—Triamcinolone—hematologic cancer	0.00118	0.00875	CrCrCtD
Betamethasone—Prednisone—Dexamethasone—hematologic cancer	0.00118	0.00872	CrCrCtD
Betamethasone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00118	0.00872	CrCrCtD
Betamethasone—Flunisolide—Dexamethasone—hematologic cancer	0.00118	0.00872	CrCrCtD
Betamethasone—Diflorasone—Dexamethasone—hematologic cancer	0.00118	0.00872	CrCrCtD
Betamethasone—Fludrocortisone—Dexamethasone—hematologic cancer	0.00118	0.00872	CrCrCtD
Betamethasone—Desonide—Dexamethasone—hematologic cancer	0.00118	0.00872	CrCrCtD
Betamethasone—CYP3A4—Methoxsalen—hematologic cancer	0.00117	0.00946	CbGbCtD
Betamethasone—Fluocortolone—Prednisolone—hematologic cancer	0.00116	0.00856	CrCrCtD
Betamethasone—Alclometasone—Prednisone—hematologic cancer	0.00115	0.00853	CrCrCtD
Betamethasone—Fludrocortisone—Triamcinolone—hematologic cancer	0.00115	0.00852	CrCrCtD
Betamethasone—Prednisone—Triamcinolone—hematologic cancer	0.00115	0.00852	CrCrCtD
Betamethasone—Diflorasone—Triamcinolone—hematologic cancer	0.00115	0.00852	CrCrCtD
Betamethasone—Flunisolide—Triamcinolone—hematologic cancer	0.00115	0.00852	CrCrCtD
Betamethasone—Desonide—Triamcinolone—hematologic cancer	0.00115	0.00852	CrCrCtD
Betamethasone—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00115	0.00852	CrCrCtD
Betamethasone—Paramethasone—Dexamethasone—hematologic cancer	0.00115	0.0085	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00113	0.00833	CrCrCtD
Betamethasone—Alclometasone—Prednisolone—hematologic cancer	0.00113	0.00833	CrCrCtD
Betamethasone—Paramethasone—Triamcinolone—hematologic cancer	0.00112	0.00831	CrCrCtD
Betamethasone—Amcinonide—Prednisone—hematologic cancer	0.00112	0.0083	CrCrCtD
Betamethasone—Budesonide—Prednisone—hematologic cancer	0.00112	0.0083	CrCrCtD
Betamethasone—Desoximetasone—Dexamethasone—hematologic cancer	0.00112	0.0083	CrCrCtD
Betamethasone—CYP3A4—Bortezomib—hematologic cancer	0.00111	0.00899	CbGbCtD
Betamethasone—Desoximetasone—Triamcinolone—hematologic cancer	0.0011	0.00811	CrCrCtD
Betamethasone—Budesonide—Prednisolone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Amcinonide—Prednisolone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Fluoxymesterone—Prednisolone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Fluorometholone—Dexamethasone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Triamcinolone—Dexamethasone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Mometasone—Dexamethasone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Loteprednol—Dexamethasone—hematologic cancer	0.0011	0.0081	CrCrCtD
Betamethasone—Flunisolide—Prednisone—hematologic cancer	0.00109	0.00809	CrCrCtD
Betamethasone—Fludrocortisone—Prednisone—hematologic cancer	0.00109	0.00809	CrCrCtD
Betamethasone—Desonide—Prednisone—hematologic cancer	0.00109	0.00809	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisone—hematologic cancer	0.00109	0.00809	CrCrCtD
Betamethasone—Diflorasone—Prednisone—hematologic cancer	0.00109	0.00809	CrCrCtD
Betamethasone—ABCB1—Dasatinib—hematologic cancer	0.00109	0.00883	CbGbCtD
Betamethasone—ABCB1—Mitoxantrone—hematologic cancer	0.00108	0.00873	CbGbCtD
Betamethasone—Rimexolone—Dexamethasone—hematologic cancer	0.00107	0.00791	CrCrCtD
Betamethasone—Fluorometholone—Triamcinolone—hematologic cancer	0.00107	0.00791	CrCrCtD
Betamethasone—Mometasone—Triamcinolone—hematologic cancer	0.00107	0.00791	CrCrCtD
Betamethasone—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00107	0.00791	CrCrCtD
Betamethasone—Loteprednol—Triamcinolone—hematologic cancer	0.00107	0.00791	CrCrCtD
Betamethasone—Prednisone—Prednisolone—hematologic cancer	0.00107	0.00789	CrCrCtD
Betamethasone—Diflorasone—Prednisolone—hematologic cancer	0.00107	0.00789	CrCrCtD
Betamethasone—Flunisolide—Prednisolone—hematologic cancer	0.00107	0.00789	CrCrCtD
Betamethasone—Fludrocortisone—Prednisolone—hematologic cancer	0.00107	0.00789	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisolone—hematologic cancer	0.00107	0.00789	CrCrCtD
Betamethasone—Desonide—Prednisolone—hematologic cancer	0.00107	0.00789	CrCrCtD
Betamethasone—Paramethasone—Prednisone—hematologic cancer	0.00107	0.00788	CrCrCtD
Betamethasone—CYP3A4—Daunorubicin—hematologic cancer	0.00106	0.0086	CbGbCtD
Betamethasone—Dexamethasone—Triamcinolone—hematologic cancer	0.00105	0.00773	CrCrCtD
Betamethasone—Rimexolone—Triamcinolone—hematologic cancer	0.00105	0.00773	CrCrCtD
Betamethasone—Paramethasone—Prednisolone—hematologic cancer	0.00104	0.0077	CrCrCtD
Betamethasone—Desoximetasone—Prednisone—hematologic cancer	0.00104	0.00769	CrCrCtD
Betamethasone—Methylprednisolone—Dexamethasone—hematologic cancer	0.00102	0.00757	CrCrCtD
Betamethasone—Triamcinolone—Prednisone—hematologic cancer	0.00102	0.00751	CrCrCtD
Betamethasone—Mometasone—Prednisone—hematologic cancer	0.00102	0.00751	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00102	0.00751	CrCrCtD
Betamethasone—Loteprednol—Prednisone—hematologic cancer	0.00102	0.00751	CrCrCtD
Betamethasone—Fluorometholone—Prednisone—hematologic cancer	0.00102	0.00751	CrCrCtD
Betamethasone—Desoximetasone—Prednisolone—hematologic cancer	0.00102	0.00751	CrCrCtD
Betamethasone—Prednisolone—Dexamethasone—hematologic cancer	0.001	0.00741	CrCrCtD
Betamethasone—Methylprednisolone—Triamcinolone—hematologic cancer	0.001	0.0074	CrCrCtD
Betamethasone—Rimexolone—Prednisone—hematologic cancer	0.000992	0.00734	CrCrCtD
Betamethasone—Dexamethasone—Prednisone—hematologic cancer	0.000992	0.00734	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.000991	0.00733	CrCrCtD
Betamethasone—Fluorometholone—Prednisolone—hematologic cancer	0.000991	0.00733	CrCrCtD
Betamethasone—Mometasone—Prednisolone—hematologic cancer	0.000991	0.00733	CrCrCtD
Betamethasone—Triamcinolone—Prednisolone—hematologic cancer	0.000991	0.00733	CrCrCtD
Betamethasone—Loteprednol—Prednisolone—hematologic cancer	0.000991	0.00733	CrCrCtD
Betamethasone—Prednisolone—Triamcinolone—hematologic cancer	0.000979	0.00724	CrCrCtD
Betamethasone—Rimexolone—Prednisolone—hematologic cancer	0.000969	0.00716	CrCrCtD
Betamethasone—Dexamethasone—Prednisolone—hematologic cancer	0.000969	0.00716	CrCrCtD
Betamethasone—Hydrocortisone—Dexamethasone—hematologic cancer	0.000962	0.00711	CrCrCtD
Betamethasone—ABCB1—Gemcitabine—hematologic cancer	0.000953	0.00771	CbGbCtD
Betamethasone—ABCB1—Prednisolone—hematologic cancer	0.000949	0.00767	CbGbCtD
Betamethasone—Methylprednisolone—Prednisone—hematologic cancer	0.000949	0.00702	CrCrCtD
Betamethasone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00094	0.00695	CrCrCtD
Betamethasone—CYP3A4—Cytarabine—hematologic cancer	0.000939	0.00759	CbGbCtD
Betamethasone—Prednisolone—Prednisone—hematologic cancer	0.000929	0.00687	CrCrCtD
Betamethasone—Methylprednisolone—Prednisolone—hematologic cancer	0.000926	0.00685	CrCrCtD
Betamethasone—CYP3A4—Teniposide—hematologic cancer	0.000925	0.00748	CbGbCtD
Betamethasone—ABCB1—Prednisone—hematologic cancer	0.000896	0.00725	CbGbCtD
Betamethasone—Hydrocortisone—Prednisone—hematologic cancer	0.000892	0.0066	CrCrCtD
Betamethasone—Hydrocortisone—Prednisolone—hematologic cancer	0.00087	0.00644	CrCrCtD
Betamethasone—CYP3A4—Ifosfamide—hematologic cancer	0.000853	0.0069	CbGbCtD
Betamethasone—ABCB1—Irinotecan—hematologic cancer	0.00085	0.00687	CbGbCtD
Betamethasone—CYP3A4—Imatinib—hematologic cancer	0.000815	0.00659	CbGbCtD
Betamethasone—CYP3A4—Ruxolitinib—hematologic cancer	0.000768	0.00621	CbGbCtD
Betamethasone—ABCB1—Vinblastine—hematologic cancer	0.000756	0.00611	CbGbCtD
Betamethasone—ABCB1—Vincristine—hematologic cancer	0.000743	0.006	CbGbCtD
Betamethasone—CYP3A4—Nilotinib—hematologic cancer	0.000741	0.00599	CbGbCtD
Betamethasone—CYP3A4—Vinorelbine—hematologic cancer	0.000735	0.00594	CbGbCtD
Betamethasone—ABCB1—Cisplatin—hematologic cancer	0.000693	0.0056	CbGbCtD
Betamethasone—ABCB1—Etoposide—hematologic cancer	0.000681	0.0055	CbGbCtD
Betamethasone—CYP3A4—Triamcinolone—hematologic cancer	0.000672	0.00543	CbGbCtD
Betamethasone—CYP3A4—Dasatinib—hematologic cancer	0.000655	0.00529	CbGbCtD
Betamethasone—PLA2G1B—hematopoietic system—hematologic cancer	0.000654	0.0517	CbGeAlD
Betamethasone—CYP3A4—Mitoxantrone—hematologic cancer	0.000647	0.00523	CbGbCtD
Betamethasone—CYP3A4—Prednisolone—hematologic cancer	0.000569	0.0046	CbGbCtD
Betamethasone—ABCB1—Dexamethasone—hematologic cancer	0.00056	0.00452	CbGbCtD
Betamethasone—CYP3A4—Prednisone—hematologic cancer	0.000537	0.00434	CbGbCtD
Betamethasone—CYP3A4—Irinotecan—hematologic cancer	0.000509	0.00412	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—hematologic cancer	0.000464	0.00375	CbGbCtD
Betamethasone—CYP3A4—Vinblastine—hematologic cancer	0.000453	0.00366	CbGbCtD
Betamethasone—ABCB1—Methotrexate—hematologic cancer	0.00045	0.00364	CbGbCtD
Betamethasone—CYP3A4—Vincristine—hematologic cancer	0.000445	0.0036	CbGbCtD
Betamethasone—PLA2G1B—blood—hematologic cancer	0.000433	0.0343	CbGeAlD
Betamethasone—CYP3A4—Etoposide—hematologic cancer	0.000408	0.0033	CbGbCtD
Betamethasone—PLA2G1B—lung—hematologic cancer	0.00038	0.03	CbGeAlD
Betamethasone—PLA2G1B—testis—hematologic cancer	0.000358	0.0283	CbGeAlD
Betamethasone—CYP3A4—Dexamethasone—hematologic cancer	0.000335	0.00271	CbGbCtD
Betamethasone—NR3C2—hematopoietic system—hematologic cancer	0.000324	0.0256	CbGeAlD
Betamethasone—PGR—hematopoietic system—hematologic cancer	0.000301	0.0238	CbGeAlD
Betamethasone—CYP3A4—Doxorubicin—hematologic cancer	0.000278	0.00225	CbGbCtD
Betamethasone—CYP19A1—hematopoietic system—hematologic cancer	0.000271	0.0214	CbGeAlD
Betamethasone—NR3C2—blood—hematologic cancer	0.000214	0.017	CbGeAlD
Betamethasone—CYP19A1—gonad—hematologic cancer	0.000206	0.0163	CbGeAlD
Betamethasone—PGR—blood—hematologic cancer	0.000199	0.0158	CbGeAlD
Betamethasone—NR3C2—lung—hematologic cancer	0.000188	0.0149	CbGeAlD
Betamethasone—CYP19A1—blood—hematologic cancer	0.000179	0.0142	CbGeAlD
Betamethasone—NR3C2—testis—hematologic cancer	0.000177	0.014	CbGeAlD
Betamethasone—PGR—lung—hematologic cancer	0.000175	0.0138	CbGeAlD
Betamethasone—NR3C1—hematopoietic system—hematologic cancer	0.000174	0.0137	CbGeAlD
Betamethasone—PGR—testis—hematologic cancer	0.000165	0.013	CbGeAlD
Betamethasone—PTGS2—hematopoietic system—hematologic cancer	0.00015	0.0119	CbGeAlD
Betamethasone—CYP19A1—testis—hematologic cancer	0.000148	0.0117	CbGeAlD
Betamethasone—NR3C1—gonad—hematologic cancer	0.000132	0.0104	CbGeAlD
Betamethasone—CYP3A4—hematopoietic system—hematologic cancer	0.000131	0.0104	CbGeAlD
Betamethasone—NR3C2—lymph node—hematologic cancer	0.000129	0.0102	CbGeAlD
Betamethasone—PGR—lymph node—hematologic cancer	0.00012	0.00945	CbGeAlD
Betamethasone—NR3C1—blood—hematologic cancer	0.000115	0.0091	CbGeAlD
Betamethasone—NR3C1—bone marrow—hematologic cancer	0.000111	0.0088	CbGeAlD
Betamethasone—CYP19A1—lymph node—hematologic cancer	0.000108	0.00851	CbGeAlD
Betamethasone—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000102	0.315	CbGdCrCtD
Betamethasone—NR3C1—lung—hematologic cancer	0.000101	0.00798	CbGeAlD
Betamethasone—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.0001	0.308	CbGdCrCtD
Betamethasone—PTGS2—blood—hematologic cancer	9.96e-05	0.00787	CbGeAlD
Betamethasone—PTGS2—bone marrow—hematologic cancer	9.63e-05	0.00762	CbGeAlD
Betamethasone—NR3C1—testis—hematologic cancer	9.52e-05	0.00753	CbGeAlD
Betamethasone—ABCB1—hematopoietic system—hematologic cancer	9.3e-05	0.00735	CbGeAlD
Betamethasone—PTGS2—lung—hematologic cancer	8.73e-05	0.0069	CbGeAlD
Betamethasone—CYP3A4—blood—hematologic cancer	8.7e-05	0.00688	CbGeAlD
Betamethasone—ABCB1—gonad—hematologic cancer	7.07e-05	0.00559	CbGeAlD
Betamethasone—NR3C1—lymph node—hematologic cancer	6.9e-05	0.00546	CbGeAlD
Betamethasone—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	6.18e-05	0.19	CbGdCrCtD
Betamethasone—ABCB1—blood—hematologic cancer	6.16e-05	0.00487	CbGeAlD
Betamethasone—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	6.04e-05	0.186	CbGdCrCtD
Betamethasone—PTGS2—lymph node—hematologic cancer	5.97e-05	0.00472	CbGeAlD
Betamethasone—ABCB1—bone marrow—hematologic cancer	5.96e-05	0.00471	CbGeAlD
Betamethasone—ABCB1—lung—hematologic cancer	5.4e-05	0.00427	CbGeAlD
Betamethasone—ABCB1—testis—hematologic cancer	5.09e-05	0.00403	CbGeAlD
Betamethasone—Difluprednate—NR3C1—hematologic cancer	3.7e-05	0.0398	CrCbGaD
Betamethasone—ABCB1—lymph node—hematologic cancer	3.69e-05	0.00292	CbGeAlD
Betamethasone—Prednicarbate—NR3C1—hematologic cancer	3.59e-05	0.0386	CrCbGaD
Betamethasone—Clocortolone—NR3C1—hematologic cancer	3.59e-05	0.0386	CrCbGaD
Betamethasone—Desonide—NR3C1—hematologic cancer	3.39e-05	0.0365	CrCbGaD
Betamethasone—Diflorasone—NR3C1—hematologic cancer	3.39e-05	0.0365	CrCbGaD
Betamethasone—Desoximetasone—NR3C1—hematologic cancer	3.31e-05	0.0356	CrCbGaD
Betamethasone—Loteprednol—NR3C1—hematologic cancer	3.27e-05	0.0352	CrCbGaD
Betamethasone—Fludrocortisone—AR—hematologic cancer	3.22e-05	0.0347	CrCbGaD
Betamethasone—Flurandrenolide—NR3C1—hematologic cancer	2.9e-05	0.0312	CrCbGaD
Betamethasone—Flumethasone Pivalate—NR3C1—hematologic cancer	2.85e-05	0.0306	CrCbGaD
Betamethasone—Halobetasol Propionate—NR3C1—hematologic cancer	2.8e-05	0.0301	CrCbGaD
Betamethasone—Fluoxymesterone—AR—hematologic cancer	2.66e-05	0.0286	CrCbGaD
Betamethasone—Amcinonide—NR3C1—hematologic cancer	2.61e-05	0.028	CrCbGaD
Betamethasone—Budesonide—NR3C1—hematologic cancer	2.61e-05	0.028	CrCbGaD
Betamethasone—Fluticasone furoate—NR3C1—hematologic cancer	2.56e-05	0.0275	CrCbGaD
Betamethasone—Mometasone—NR3C1—hematologic cancer	2.48e-05	0.0267	CrCbGaD
Betamethasone—Rimexolone—NR3C1—hematologic cancer	2.45e-05	0.0264	CrCbGaD
Betamethasone—Beclomethasone—NR3C1—hematologic cancer	2.31e-05	0.0249	CrCbGaD
Betamethasone—Fluocinonide—NR3C1—hematologic cancer	2.31e-05	0.0249	CrCbGaD
Betamethasone—Fluocinolone Acetonide—NR3C1—hematologic cancer	2.25e-05	0.0242	CrCbGaD
Betamethasone—Alclometasone—NR3C1—hematologic cancer	2.25e-05	0.0242	CrCbGaD
Betamethasone—Clobetasol propionate—NR3C1—hematologic cancer	2.19e-05	0.0235	CrCbGaD
Betamethasone—Flunisolide—NR3C1—hematologic cancer	2.19e-05	0.0235	CrCbGaD
Betamethasone—Fludrocortisone—NR3C1—hematologic cancer	2.19e-05	0.0235	CrCbGaD
Betamethasone—Paramethasone—NR3C1—hematologic cancer	2.16e-05	0.0232	CrCbGaD
Betamethasone—Fluorometholone—NR3C1—hematologic cancer	2.11e-05	0.0227	CrCbGaD
Betamethasone—Fluoxymesterone—ESR1—hematologic cancer	2.05e-05	0.0221	CrCbGaD
Betamethasone—Methylprednisolone—NR3C1—hematologic cancer	2.04e-05	0.0219	CrCbGaD
Betamethasone—Fluoxymesterone—NR3C1—hematologic cancer	1.81e-05	0.0194	CrCbGaD
Betamethasone—Triamcinolone—NR3C1—hematologic cancer	1.72e-05	0.0185	CrCbGaD
Betamethasone—Prednisone—NR3C1—hematologic cancer	1.56e-05	0.0168	CrCbGaD
Betamethasone—Fluticasone Propionate—NR3C1—hematologic cancer	1.54e-05	0.0165	CrCbGaD
Betamethasone—Prednisolone—NR3C1—hematologic cancer	1.44e-05	0.0154	CrCbGaD
Betamethasone—Hydrocortisone—ABCG2—hematologic cancer	1.27e-05	0.0137	CrCbGaD
Betamethasone—Fluticasone furoate—ABCB1—hematologic cancer	1.23e-05	0.0133	CrCbGaD
Betamethasone—Hydrocortisone—NR3C1—hematologic cancer	1.1e-05	0.0118	CrCbGaD
Betamethasone—Methylprednisolone—ABCB1—hematologic cancer	9.83e-06	0.0106	CrCbGaD
Betamethasone—Dexamethasone—ABCG2—hematologic cancer	9.49e-06	0.0102	CrCbGaD
Betamethasone—Dexamethasone—NR3C1—hematologic cancer	8.19e-06	0.0088	CrCbGaD
Betamethasone—Prednisone—ALB—hematologic cancer	7.88e-06	0.00847	CrCbGaD
Betamethasone—Prednisone—ABCB1—hematologic cancer	7.52e-06	0.00809	CrCbGaD
Betamethasone—Prednisolone—ABCB1—hematologic cancer	6.93e-06	0.00745	CrCbGaD
Betamethasone—Hydrocortisone—ABCB1—hematologic cancer	5.3e-06	0.0057	CrCbGaD
Betamethasone—Dexamethasone—ABCB1—hematologic cancer	3.95e-06	0.00425	CrCbGaD
Betamethasone—Urticaria—Prednisolone—hematologic cancer	3.46e-06	6.04e-05	CcSEcCtD
Betamethasone—Asthenia—Cisplatin—hematologic cancer	3.46e-06	6.04e-05	CcSEcCtD
Betamethasone—Fatigue—Triamcinolone—hematologic cancer	3.46e-06	6.03e-05	CcSEcCtD
Betamethasone—Rash—Vincristine—hematologic cancer	3.44e-06	6e-05	CcSEcCtD
Betamethasone—Dermatitis—Vincristine—hematologic cancer	3.44e-06	5.99e-05	CcSEcCtD
Betamethasone—Pain—Triamcinolone—hematologic cancer	3.43e-06	5.98e-05	CcSEcCtD
Betamethasone—Headache—Vincristine—hematologic cancer	3.42e-06	5.96e-05	CcSEcCtD
Betamethasone—Loss of consciousness—Prednisone—hematologic cancer	3.41e-06	5.95e-05	CcSEcCtD
Betamethasone—Hypotension—Dexamethasone—hematologic cancer	3.4e-06	5.93e-05	CcSEcCtD
Betamethasone—Nausea—Carmustine—hematologic cancer	3.39e-06	5.92e-05	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—hematologic cancer	3.38e-06	5.9e-05	CcSEcCtD
Betamethasone—Vomiting—Mitoxantrone—hematologic cancer	3.38e-06	5.89e-05	CcSEcCtD
Betamethasone—Vomiting—Irinotecan—hematologic cancer	3.38e-06	5.89e-05	CcSEcCtD
Betamethasone—Nausea—Alitretinoin—hematologic cancer	3.36e-06	5.87e-05	CcSEcCtD
Betamethasone—Convulsion—Prednisone—hematologic cancer	3.36e-06	5.86e-05	CcSEcCtD
Betamethasone—Visual impairment—Epirubicin—hematologic cancer	3.36e-06	5.86e-05	CcSEcCtD
Betamethasone—Hypertension—Prednisone—hematologic cancer	3.35e-06	5.84e-05	CcSEcCtD
Betamethasone—Rash—Irinotecan—hematologic cancer	3.35e-06	5.84e-05	CcSEcCtD
Betamethasone—Rash—Mitoxantrone—hematologic cancer	3.35e-06	5.84e-05	CcSEcCtD
Betamethasone—Dermatitis—Irinotecan—hematologic cancer	3.35e-06	5.84e-05	CcSEcCtD
Betamethasone—Dermatitis—Mitoxantrone—hematologic cancer	3.35e-06	5.84e-05	CcSEcCtD
Betamethasone—Headache—Mitoxantrone—hematologic cancer	3.33e-06	5.81e-05	CcSEcCtD
Betamethasone—Headache—Irinotecan—hematologic cancer	3.33e-06	5.81e-05	CcSEcCtD
Betamethasone—Nausea—Ifosfamide—hematologic cancer	3.32e-06	5.8e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.31e-06	5.78e-05	CcSEcCtD
Betamethasone—Myalgia—Prednisone—hematologic cancer	3.3e-06	5.76e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Triamcinolone—hematologic cancer	3.3e-06	5.76e-05	CcSEcCtD
Betamethasone—Diarrhoea—Cisplatin—hematologic cancer	3.3e-06	5.76e-05	CcSEcCtD
Betamethasone—Anxiety—Prednisone—hematologic cancer	3.29e-06	5.74e-05	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—hematologic cancer	3.29e-06	5.74e-05	CcSEcCtD
Betamethasone—Vomiting—Gemcitabine—hematologic cancer	3.29e-06	5.74e-05	CcSEcCtD
Betamethasone—Insomnia—Dexamethasone—hematologic cancer	3.29e-06	5.74e-05	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—hematologic cancer	3.28e-06	5.73e-05	CcSEcCtD
Betamethasone—Paraesthesia—Dexamethasone—hematologic cancer	3.27e-06	5.7e-05	CcSEcCtD
Betamethasone—Discomfort—Prednisone—hematologic cancer	3.26e-06	5.69e-05	CcSEcCtD
Betamethasone—Rash—Gemcitabine—hematologic cancer	3.26e-06	5.69e-05	CcSEcCtD
Betamethasone—Dermatitis—Gemcitabine—hematologic cancer	3.26e-06	5.69e-05	CcSEcCtD
Betamethasone—Eye disorder—Epirubicin—hematologic cancer	3.26e-06	5.68e-05	CcSEcCtD
Betamethasone—Erythema—Methotrexate—hematologic cancer	3.24e-06	5.66e-05	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—hematologic cancer	3.24e-06	5.66e-05	CcSEcCtD
Betamethasone—Headache—Gemcitabine—hematologic cancer	3.24e-06	5.65e-05	CcSEcCtD
Betamethasone—Nausea—Vincristine—hematologic cancer	3.24e-06	5.65e-05	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—hematologic cancer	3.23e-06	5.63e-05	CcSEcCtD
Betamethasone—Dyspepsia—Dexamethasone—hematologic cancer	3.2e-06	5.58e-05	CcSEcCtD
Betamethasone—Urticaria—Triamcinolone—hematologic cancer	3.18e-06	5.55e-05	CcSEcCtD
Betamethasone—Asthenia—Etoposide—hematologic cancer	3.17e-06	5.53e-05	CcSEcCtD
Betamethasone—Body temperature increased—Triamcinolone—hematologic cancer	3.17e-06	5.53e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Prednisone—hematologic cancer	3.17e-06	5.52e-05	CcSEcCtD
Betamethasone—Oedema—Prednisone—hematologic cancer	3.17e-06	5.52e-05	CcSEcCtD
Betamethasone—Angiopathy—Epirubicin—hematologic cancer	3.16e-06	5.52e-05	CcSEcCtD
Betamethasone—Decreased appetite—Dexamethasone—hematologic cancer	3.16e-06	5.51e-05	CcSEcCtD
Betamethasone—Nausea—Mitoxantrone—hematologic cancer	3.16e-06	5.5e-05	CcSEcCtD
Betamethasone—Nausea—Irinotecan—hematologic cancer	3.16e-06	5.5e-05	CcSEcCtD
Betamethasone—Infection—Prednisone—hematologic cancer	3.15e-06	5.49e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.14e-06	5.48e-05	CcSEcCtD
Betamethasone—Fatigue—Dexamethasone—hematologic cancer	3.13e-06	5.47e-05	CcSEcCtD
Betamethasone—Pruritus—Etoposide—hematologic cancer	3.13e-06	5.45e-05	CcSEcCtD
Betamethasone—Shock—Prednisone—hematologic cancer	3.12e-06	5.44e-05	CcSEcCtD
Betamethasone—Arrhythmia—Epirubicin—hematologic cancer	3.11e-06	5.43e-05	CcSEcCtD
Betamethasone—Pain—Dexamethasone—hematologic cancer	3.11e-06	5.42e-05	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—hematologic cancer	3.11e-06	5.42e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Prednisone—hematologic cancer	3.11e-06	5.42e-05	CcSEcCtD
Betamethasone—Tachycardia—Prednisone—hematologic cancer	3.09e-06	5.39e-05	CcSEcCtD
Betamethasone—Alopecia—Epirubicin—hematologic cancer	3.08e-06	5.37e-05	CcSEcCtD
Betamethasone—Nausea—Gemcitabine—hematologic cancer	3.07e-06	5.36e-05	CcSEcCtD
Betamethasone—Vomiting—Cisplatin—hematologic cancer	3.07e-06	5.35e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisone—hematologic cancer	3.06e-06	5.34e-05	CcSEcCtD
Betamethasone—Rash—Cisplatin—hematologic cancer	3.04e-06	5.3e-05	CcSEcCtD
Betamethasone—Dermatitis—Cisplatin—hematologic cancer	3.04e-06	5.3e-05	CcSEcCtD
Betamethasone—Erythema—Epirubicin—hematologic cancer	3.03e-06	5.29e-05	CcSEcCtD
Betamethasone—Diarrhoea—Etoposide—hematologic cancer	3.02e-06	5.27e-05	CcSEcCtD
Betamethasone—Anorexia—Prednisone—hematologic cancer	3.02e-06	5.27e-05	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—hematologic cancer	3.01e-06	5.26e-05	CcSEcCtD
Betamethasone—Ill-defined disorder—Methotrexate—hematologic cancer	3.01e-06	5.25e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Dexamethasone—hematologic cancer	3e-06	5.23e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.97e-06	5.19e-05	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—hematologic cancer	2.93e-06	5.11e-05	CcSEcCtD
Betamethasone—Malaise—Methotrexate—hematologic cancer	2.92e-06	5.1e-05	CcSEcCtD
Betamethasone—Dizziness—Etoposide—hematologic cancer	2.92e-06	5.1e-05	CcSEcCtD
Betamethasone—Vertigo—Methotrexate—hematologic cancer	2.91e-06	5.08e-05	CcSEcCtD
Betamethasone—Urticaria—Dexamethasone—hematologic cancer	2.89e-06	5.04e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.89e-06	5.03e-05	CcSEcCtD
Betamethasone—Dizziness—Prednisolone—hematologic cancer	2.88e-06	5.03e-05	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—hematologic cancer	2.88e-06	5.03e-05	CcSEcCtD
Betamethasone—Asthenia—Triamcinolone—hematologic cancer	2.88e-06	5.02e-05	CcSEcCtD
Betamethasone—Abdominal pain—Dexamethasone—hematologic cancer	2.87e-06	5.01e-05	CcSEcCtD
Betamethasone—Body temperature increased—Dexamethasone—hematologic cancer	2.87e-06	5.01e-05	CcSEcCtD
Betamethasone—Nausea—Cisplatin—hematologic cancer	2.86e-06	5e-05	CcSEcCtD
Betamethasone—Insomnia—Prednisone—hematologic cancer	2.86e-06	5e-05	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—hematologic cancer	2.85e-06	4.97e-05	CcSEcCtD
Betamethasone—Paraesthesia—Prednisone—hematologic cancer	2.84e-06	4.96e-05	CcSEcCtD
Betamethasone—Pruritus—Triamcinolone—hematologic cancer	2.84e-06	4.95e-05	CcSEcCtD
Betamethasone—Ill-defined disorder—Epirubicin—hematologic cancer	2.82e-06	4.91e-05	CcSEcCtD
Betamethasone—Convulsion—Methotrexate—hematologic cancer	2.81e-06	4.9e-05	CcSEcCtD
Betamethasone—Vomiting—Etoposide—hematologic cancer	2.81e-06	4.9e-05	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—hematologic cancer	2.81e-06	4.9e-05	CcSEcCtD
Betamethasone—Dyspepsia—Prednisone—hematologic cancer	2.79e-06	4.86e-05	CcSEcCtD
Betamethasone—Rash—Etoposide—hematologic cancer	2.79e-06	4.86e-05	CcSEcCtD
Betamethasone—Dermatitis—Etoposide—hematologic cancer	2.78e-06	4.86e-05	CcSEcCtD
Betamethasone—Headache—Etoposide—hematologic cancer	2.77e-06	4.83e-05	CcSEcCtD
Betamethasone—Myalgia—Methotrexate—hematologic cancer	2.76e-06	4.82e-05	CcSEcCtD
Betamethasone—Decreased appetite—Prednisone—hematologic cancer	2.75e-06	4.8e-05	CcSEcCtD
Betamethasone—Rash—Prednisolone—hematologic cancer	2.75e-06	4.79e-05	CcSEcCtD
Betamethasone—Dermatitis—Prednisolone—hematologic cancer	2.75e-06	4.79e-05	CcSEcCtD
Betamethasone—Malaise—Epirubicin—hematologic cancer	2.74e-06	4.77e-05	CcSEcCtD
Betamethasone—Fatigue—Prednisone—hematologic cancer	2.73e-06	4.76e-05	CcSEcCtD
Betamethasone—Headache—Prednisolone—hematologic cancer	2.73e-06	4.76e-05	CcSEcCtD
Betamethasone—Discomfort—Methotrexate—hematologic cancer	2.73e-06	4.76e-05	CcSEcCtD
Betamethasone—Vertigo—Epirubicin—hematologic cancer	2.73e-06	4.76e-05	CcSEcCtD
Betamethasone—Syncope—Epirubicin—hematologic cancer	2.72e-06	4.75e-05	CcSEcCtD
Betamethasone—Loss of consciousness—Epirubicin—hematologic cancer	2.67e-06	4.65e-05	CcSEcCtD
Betamethasone—Dizziness—Triamcinolone—hematologic cancer	2.65e-06	4.62e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Methotrexate—hematologic cancer	2.65e-06	4.62e-05	CcSEcCtD
Betamethasone—Convulsion—Epirubicin—hematologic cancer	2.63e-06	4.59e-05	CcSEcCtD
Betamethasone—Infection—Methotrexate—hematologic cancer	2.63e-06	4.59e-05	CcSEcCtD
Betamethasone—Nausea—Etoposide—hematologic cancer	2.62e-06	4.58e-05	CcSEcCtD
Betamethasone—Hypertension—Epirubicin—hematologic cancer	2.62e-06	4.57e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Prednisone—hematologic cancer	2.61e-06	4.55e-05	CcSEcCtD
Betamethasone—Asthenia—Dexamethasone—hematologic cancer	2.61e-06	4.55e-05	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.61e-06	4.54e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Methotrexate—hematologic cancer	2.6e-06	4.53e-05	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—hematologic cancer	2.59e-06	4.52e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Prednisone—hematologic cancer	2.59e-06	4.52e-05	CcSEcCtD
Betamethasone—Nausea—Prednisolone—hematologic cancer	2.59e-06	4.52e-05	CcSEcCtD
Betamethasone—Myalgia—Epirubicin—hematologic cancer	2.58e-06	4.51e-05	CcSEcCtD
Betamethasone—Anxiety—Epirubicin—hematologic cancer	2.57e-06	4.49e-05	CcSEcCtD
Betamethasone—Pruritus—Dexamethasone—hematologic cancer	2.57e-06	4.49e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Methotrexate—hematologic cancer	2.56e-06	4.46e-05	CcSEcCtD
Betamethasone—Discomfort—Epirubicin—hematologic cancer	2.55e-06	4.45e-05	CcSEcCtD
Betamethasone—Vomiting—Triamcinolone—hematologic cancer	2.55e-06	4.45e-05	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—hematologic cancer	2.53e-06	4.42e-05	CcSEcCtD
Betamethasone—Rash—Triamcinolone—hematologic cancer	2.53e-06	4.41e-05	CcSEcCtD
Betamethasone—Dermatitis—Triamcinolone—hematologic cancer	2.52e-06	4.4e-05	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—hematologic cancer	2.52e-06	4.4e-05	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—hematologic cancer	2.52e-06	4.4e-05	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—hematologic cancer	2.52e-06	4.39e-05	CcSEcCtD
Betamethasone—Urticaria—Prednisone—hematologic cancer	2.52e-06	4.39e-05	CcSEcCtD
Betamethasone—Headache—Triamcinolone—hematologic cancer	2.51e-06	4.38e-05	CcSEcCtD
Betamethasone—Abdominal pain—Prednisone—hematologic cancer	2.5e-06	4.37e-05	CcSEcCtD
Betamethasone—Body temperature increased—Prednisone—hematologic cancer	2.5e-06	4.37e-05	CcSEcCtD
Betamethasone—Diarrhoea—Dexamethasone—hematologic cancer	2.49e-06	4.34e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Epirubicin—hematologic cancer	2.48e-06	4.32e-05	CcSEcCtD
Betamethasone—Oedema—Epirubicin—hematologic cancer	2.48e-06	4.32e-05	CcSEcCtD
Betamethasone—Hypotension—Methotrexate—hematologic cancer	2.47e-06	4.31e-05	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—hematologic cancer	2.47e-06	4.31e-05	CcSEcCtD
Betamethasone—Infection—Epirubicin—hematologic cancer	2.46e-06	4.29e-05	CcSEcCtD
Betamethasone—Shock—Epirubicin—hematologic cancer	2.44e-06	4.25e-05	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—hematologic cancer	2.43e-06	4.24e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Epirubicin—hematologic cancer	2.43e-06	4.24e-05	CcSEcCtD
Betamethasone—Thrombocytopenia—Epirubicin—hematologic cancer	2.42e-06	4.23e-05	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—hematologic cancer	2.42e-06	4.23e-05	CcSEcCtD
Betamethasone—Tachycardia—Epirubicin—hematologic cancer	2.42e-06	4.22e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.41e-06	4.21e-05	CcSEcCtD
Betamethasone—Dizziness—Dexamethasone—hematologic cancer	2.4e-06	4.19e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Epirubicin—hematologic cancer	2.39e-06	4.18e-05	CcSEcCtD
Betamethasone—Insomnia—Methotrexate—hematologic cancer	2.39e-06	4.18e-05	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—hematologic cancer	2.39e-06	4.17e-05	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—hematologic cancer	2.38e-06	4.16e-05	CcSEcCtD
Betamethasone—Nausea—Triamcinolone—hematologic cancer	2.38e-06	4.15e-05	CcSEcCtD
Betamethasone—Paraesthesia—Methotrexate—hematologic cancer	2.38e-06	4.15e-05	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—hematologic cancer	2.36e-06	4.12e-05	CcSEcCtD
Betamethasone—Anorexia—Epirubicin—hematologic cancer	2.36e-06	4.12e-05	CcSEcCtD
Betamethasone—Dyspepsia—Methotrexate—hematologic cancer	2.33e-06	4.06e-05	CcSEcCtD
Betamethasone—Hypotension—Epirubicin—hematologic cancer	2.31e-06	4.04e-05	CcSEcCtD
Betamethasone—Vomiting—Dexamethasone—hematologic cancer	2.31e-06	4.03e-05	CcSEcCtD
Betamethasone—Decreased appetite—Methotrexate—hematologic cancer	2.3e-06	4.01e-05	CcSEcCtD
Betamethasone—Rash—Dexamethasone—hematologic cancer	2.29e-06	4e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.29e-06	4e-05	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—hematologic cancer	2.29e-06	4e-05	CcSEcCtD
Betamethasone—Dermatitis—Dexamethasone—hematologic cancer	2.29e-06	4e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.28e-06	3.99e-05	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—hematologic cancer	2.28e-06	3.98e-05	CcSEcCtD
Betamethasone—Headache—Dexamethasone—hematologic cancer	2.28e-06	3.97e-05	CcSEcCtD
Betamethasone—Infection—Doxorubicin—hematologic cancer	2.28e-06	3.97e-05	CcSEcCtD
Betamethasone—Asthenia—Prednisone—hematologic cancer	2.27e-06	3.96e-05	CcSEcCtD
Betamethasone—Pain—Methotrexate—hematologic cancer	2.26e-06	3.95e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.26e-06	3.94e-05	CcSEcCtD
Betamethasone—Shock—Doxorubicin—hematologic cancer	2.25e-06	3.93e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—hematologic cancer	2.25e-06	3.92e-05	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—hematologic cancer	2.24e-06	3.91e-05	CcSEcCtD
Betamethasone—Pruritus—Prednisone—hematologic cancer	2.24e-06	3.91e-05	CcSEcCtD
Betamethasone—Insomnia—Epirubicin—hematologic cancer	2.24e-06	3.91e-05	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—hematologic cancer	2.24e-06	3.9e-05	CcSEcCtD
Betamethasone—Paraesthesia—Epirubicin—hematologic cancer	2.22e-06	3.88e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.22e-06	3.86e-05	CcSEcCtD
Betamethasone—Anorexia—Doxorubicin—hematologic cancer	2.18e-06	3.81e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Methotrexate—hematologic cancer	2.18e-06	3.8e-05	CcSEcCtD
Betamethasone—Dyspepsia—Epirubicin—hematologic cancer	2.18e-06	3.8e-05	CcSEcCtD
Betamethasone—Diarrhoea—Prednisone—hematologic cancer	2.17e-06	3.78e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—hematologic cancer	2.16e-06	3.78e-05	CcSEcCtD
Betamethasone—Nausea—Dexamethasone—hematologic cancer	2.16e-06	3.77e-05	CcSEcCtD
Betamethasone—Decreased appetite—Epirubicin—hematologic cancer	2.15e-06	3.76e-05	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—hematologic cancer	2.14e-06	3.74e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.14e-06	3.73e-05	CcSEcCtD
Betamethasone—Fatigue—Epirubicin—hematologic cancer	2.14e-06	3.73e-05	CcSEcCtD
Betamethasone—Pain—Epirubicin—hematologic cancer	2.12e-06	3.69e-05	CcSEcCtD
Betamethasone—Urticaria—Methotrexate—hematologic cancer	2.1e-06	3.67e-05	CcSEcCtD
Betamethasone—Dizziness—Prednisone—hematologic cancer	2.09e-06	3.65e-05	CcSEcCtD
Betamethasone—Body temperature increased—Methotrexate—hematologic cancer	2.09e-06	3.65e-05	CcSEcCtD
Betamethasone—Abdominal pain—Methotrexate—hematologic cancer	2.09e-06	3.65e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.09e-06	3.64e-05	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—hematologic cancer	2.07e-06	3.62e-05	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—hematologic cancer	2.06e-06	3.59e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Epirubicin—hematologic cancer	2.04e-06	3.56e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Epirubicin—hematologic cancer	2.03e-06	3.53e-05	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—hematologic cancer	2.02e-06	3.52e-05	CcSEcCtD
Betamethasone—Vomiting—Prednisone—hematologic cancer	2.01e-06	3.51e-05	CcSEcCtD
Betamethasone—Rash—Prednisone—hematologic cancer	2e-06	3.48e-05	CcSEcCtD
Betamethasone—Dermatitis—Prednisone—hematologic cancer	1.99e-06	3.48e-05	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—hematologic cancer	1.99e-06	3.48e-05	CcSEcCtD
Betamethasone—Headache—Prednisone—hematologic cancer	1.98e-06	3.46e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.98e-06	3.45e-05	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—hematologic cancer	1.98e-06	3.45e-05	CcSEcCtD
Betamethasone—Urticaria—Epirubicin—hematologic cancer	1.97e-06	3.43e-05	CcSEcCtD
Betamethasone—Pain—Doxorubicin—hematologic cancer	1.96e-06	3.42e-05	CcSEcCtD
Betamethasone—Abdominal pain—Epirubicin—hematologic cancer	1.96e-06	3.42e-05	CcSEcCtD
Betamethasone—Body temperature increased—Epirubicin—hematologic cancer	1.96e-06	3.42e-05	CcSEcCtD
Betamethasone—Asthenia—Methotrexate—hematologic cancer	1.9e-06	3.31e-05	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—hematologic cancer	1.89e-06	3.29e-05	CcSEcCtD
Betamethasone—Nausea—Prednisone—hematologic cancer	1.88e-06	3.28e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.87e-06	3.27e-05	CcSEcCtD
Betamethasone—Pruritus—Methotrexate—hematologic cancer	1.87e-06	3.27e-05	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—hematologic cancer	1.82e-06	3.18e-05	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—hematologic cancer	1.81e-06	3.16e-05	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—hematologic cancer	1.81e-06	3.16e-05	CcSEcCtD
Betamethasone—Diarrhoea—Methotrexate—hematologic cancer	1.81e-06	3.16e-05	CcSEcCtD
Betamethasone—Asthenia—Epirubicin—hematologic cancer	1.78e-06	3.1e-05	CcSEcCtD
Betamethasone—Pruritus—Epirubicin—hematologic cancer	1.75e-06	3.06e-05	CcSEcCtD
Betamethasone—Dizziness—Methotrexate—hematologic cancer	1.75e-06	3.05e-05	CcSEcCtD
Betamethasone—Diarrhoea—Epirubicin—hematologic cancer	1.69e-06	2.96e-05	CcSEcCtD
Betamethasone—Vomiting—Methotrexate—hematologic cancer	1.68e-06	2.94e-05	CcSEcCtD
Betamethasone—Rash—Methotrexate—hematologic cancer	1.67e-06	2.91e-05	CcSEcCtD
Betamethasone—Dermatitis—Methotrexate—hematologic cancer	1.67e-06	2.91e-05	CcSEcCtD
Betamethasone—Headache—Methotrexate—hematologic cancer	1.66e-06	2.89e-05	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—hematologic cancer	1.64e-06	2.87e-05	CcSEcCtD
Betamethasone—Dizziness—Epirubicin—hematologic cancer	1.64e-06	2.86e-05	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—hematologic cancer	1.62e-06	2.83e-05	CcSEcCtD
Betamethasone—Vomiting—Epirubicin—hematologic cancer	1.57e-06	2.75e-05	CcSEcCtD
Betamethasone—Nausea—Methotrexate—hematologic cancer	1.57e-06	2.74e-05	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—hematologic cancer	1.57e-06	2.74e-05	CcSEcCtD
Betamethasone—Rash—Epirubicin—hematologic cancer	1.56e-06	2.72e-05	CcSEcCtD
Betamethasone—Dermatitis—Epirubicin—hematologic cancer	1.56e-06	2.72e-05	CcSEcCtD
Betamethasone—Headache—Epirubicin—hematologic cancer	1.55e-06	2.71e-05	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—hematologic cancer	1.52e-06	2.64e-05	CcSEcCtD
Betamethasone—PTGS2—Metabolism—SDC1—hematologic cancer	1.5e-06	7.4e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK14—hematologic cancer	1.49e-06	7.38e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOR2—hematologic cancer	1.49e-06	7.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.49e-06	7.35e-05	CbGpPWpGaD
Betamethasone—Nausea—Epirubicin—hematologic cancer	1.47e-06	2.57e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—ESR1—hematologic cancer	1.46e-06	7.24e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NCOR1—hematologic cancer	1.46e-06	7.22e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—hematologic cancer	1.46e-06	7.22e-05	CbGpPWpGaD
Betamethasone—Vomiting—Doxorubicin—hematologic cancer	1.46e-06	2.54e-05	CcSEcCtD
Betamethasone—Rash—Doxorubicin—hematologic cancer	1.44e-06	2.52e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—FN1—hematologic cancer	1.44e-06	7.15e-05	CbGpPWpGaD
Betamethasone—Dermatitis—Doxorubicin—hematologic cancer	1.44e-06	2.52e-05	CcSEcCtD
Betamethasone—CYP3A4—Metabolism—CDA—hematologic cancer	1.44e-06	7.12e-05	CbGpPWpGaD
Betamethasone—Headache—Doxorubicin—hematologic cancer	1.44e-06	2.5e-05	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.43e-06	7.07e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HSP90AA1—hematologic cancer	1.43e-06	7.07e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BAD—hematologic cancer	1.43e-06	7.06e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NFKBIA—hematologic cancer	1.43e-06	7.06e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—IDH1—hematologic cancer	1.42e-06	7e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.41e-06	7e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH1—hematologic cancer	1.41e-06	6.99e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.41e-06	6.98e-05	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	1.4e-06	6.95e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.4e-06	6.94e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TXN—hematologic cancer	1.4e-06	6.93e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTO1—hematologic cancer	1.4e-06	6.93e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCC3—hematologic cancer	1.4e-06	6.93e-05	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—hematologic cancer	1.39e-06	6.86e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PC—hematologic cancer	1.39e-06	6.86e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CD80—hematologic cancer	1.38e-06	6.85e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KIT—hematologic cancer	1.38e-06	6.84e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—hematologic cancer	1.38e-06	6.84e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT1—hematologic cancer	1.38e-06	6.82e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SPHK1—hematologic cancer	1.37e-06	6.78e-05	CbGpPWpGaD
Betamethasone—Nausea—Doxorubicin—hematologic cancer	1.36e-06	2.37e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—PTPN11—hematologic cancer	1.36e-06	6.72e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.35e-06	6.68e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GBA—hematologic cancer	1.34e-06	6.62e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.34e-06	6.62e-05	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—hematologic cancer	1.33e-06	6.59e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK14—hematologic cancer	1.33e-06	6.56e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.32e-06	6.51e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CREB1—hematologic cancer	1.32e-06	6.51e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ESR1—hematologic cancer	1.3e-06	6.43e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BRAF—hematologic cancer	1.3e-06	6.43e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—hematologic cancer	1.29e-06	6.38e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.29e-06	6.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GRB2—hematologic cancer	1.29e-06	6.38e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL2—hematologic cancer	1.29e-06	6.37e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFA—hematologic cancer	1.29e-06	6.36e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6R—hematologic cancer	1.28e-06	6.35e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CREBBP—hematologic cancer	1.28e-06	6.34e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CRABP1—hematologic cancer	1.28e-06	6.33e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.28e-06	6.33e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NQO1—hematologic cancer	1.27e-06	6.3e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CD44—hematologic cancer	1.27e-06	6.3e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KITLG—hematologic cancer	1.27e-06	6.27e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	1.26e-06	6.22e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALOX5—hematologic cancer	1.25e-06	6.17e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.25e-06	6.17e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.25e-06	6.16e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT5A—hematologic cancer	1.24e-06	6.13e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—hematologic cancer	1.23e-06	6.07e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTAP—hematologic cancer	1.22e-06	6.06e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAP2K1—hematologic cancer	1.22e-06	6.05e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CD—hematologic cancer	1.22e-06	6.01e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NUP98—hematologic cancer	1.21e-06	5.98e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYCS—hematologic cancer	1.2e-06	5.96e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAPK3—hematologic cancer	1.2e-06	5.95e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.2e-06	5.92e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD86—hematologic cancer	1.19e-06	5.88e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ADCY7—hematologic cancer	1.17e-06	5.8e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOA3—hematologic cancer	1.17e-06	5.8e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HES1—hematologic cancer	1.17e-06	5.8e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—hematologic cancer	1.17e-06	5.79e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NUP214—hematologic cancer	1.16e-06	5.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NCOR1—hematologic cancer	1.16e-06	5.76e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF2—hematologic cancer	1.16e-06	5.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF1—hematologic cancer	1.15e-06	5.7e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3R1—hematologic cancer	1.15e-06	5.68e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTR—hematologic cancer	1.14e-06	5.65e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ABCG2—hematologic cancer	1.14e-06	5.65e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CREBBP—hematologic cancer	1.14e-06	5.64e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.14e-06	5.62e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FOXO1—hematologic cancer	1.13e-06	5.62e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFRB—hematologic cancer	1.13e-06	5.61e-05	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—hematologic cancer	1.13e-06	5.6e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ENO2—hematologic cancer	1.12e-06	5.54e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JAK2—hematologic cancer	1.12e-06	5.52e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFRA—hematologic cancer	1.12e-06	5.52e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAK1—hematologic cancer	1.11e-06	5.5e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PRKCG—hematologic cancer	1.11e-06	5.5e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FHL2—hematologic cancer	1.09e-06	5.4e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MDM2—hematologic cancer	1.09e-06	5.39e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTT1—hematologic cancer	1.09e-06	5.37e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—hematologic cancer	1.08e-06	5.36e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.08e-06	5.33e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AGRN—hematologic cancer	1.07e-06	5.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTP1—hematologic cancer	1.06e-06	5.25e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SDC1—hematologic cancer	1.06e-06	5.25e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CB—hematologic cancer	1.06e-06	5.24e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MTOR—hematologic cancer	1.06e-06	5.24e-05	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.05e-06	5.21e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—hematologic cancer	1.03e-06	5.09e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.03e-06	5.08e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—hematologic cancer	1.03e-06	5.08e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HLA-A—hematologic cancer	1.03e-06	5.08e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.02e-06	5.03e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—IDH2—hematologic cancer	1.01e-06	5.02e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMMR—hematologic cancer	1.01e-06	5.02e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CREBBP—hematologic cancer	1e-06	4.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCB1—hematologic cancer	1e-06	4.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFB—hematologic cancer	1e-06	4.96e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—hematologic cancer	9.94e-07	4.92e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TSC2—hematologic cancer	9.79e-07	4.84e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—hematologic cancer	9.75e-07	4.83e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NCOR1—hematologic cancer	9.75e-07	4.83e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—hematologic cancer	9.74e-07	4.82e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—hematologic cancer	9.73e-07	4.81e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.54e-07	4.72e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CD—hematologic cancer	9.53e-07	4.71e-05	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	9.51e-07	4.71e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—hematologic cancer	9.48e-07	4.69e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JUN—hematologic cancer	9.46e-07	4.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR3—hematologic cancer	9.42e-07	4.66e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—hematologic cancer	9.41e-07	4.65e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA9—hematologic cancer	9.28e-07	4.59e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACP5—hematologic cancer	9.28e-07	4.59e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1A—hematologic cancer	9.17e-07	4.54e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOR2—hematologic cancer	9.16e-07	4.53e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—hematologic cancer	9.15e-07	4.53e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NQO1—hematologic cancer	9.02e-07	4.46e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CD44—hematologic cancer	9.02e-07	4.46e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3R1—hematologic cancer	9e-07	4.45e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK8—hematologic cancer	8.95e-07	4.43e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BAD—hematologic cancer	8.93e-07	4.42e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOTCH1—hematologic cancer	8.84e-07	4.38e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EP300—hematologic cancer	8.73e-07	4.32e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—IDH1—hematologic cancer	8.72e-07	4.32e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD80—hematologic cancer	8.66e-07	4.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KIT—hematologic cancer	8.65e-07	4.28e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TXN—hematologic cancer	8.62e-07	4.27e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.62e-07	4.27e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.62e-07	4.27e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—hematologic cancer	8.62e-07	4.26e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYCS—hematologic cancer	8.54e-07	4.22e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTPN11—hematologic cancer	8.5e-07	4.2e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SRC—hematologic cancer	8.49e-07	4.2e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	8.48e-07	4.2e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.44e-07	4.18e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CB—hematologic cancer	8.3e-07	4.11e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—hematologic cancer	8.27e-07	4.09e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CREB1—hematologic cancer	8.23e-07	4.07e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—hematologic cancer	8.19e-07	4.05e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRAS—hematologic cancer	8.17e-07	4.04e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BRAF—hematologic cancer	8.13e-07	4.02e-05	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—hematologic cancer	8.11e-07	4.01e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	8.11e-07	4.01e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6R—hematologic cancer	8.03e-07	3.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CREBBP—hematologic cancer	8.02e-07	3.97e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.89e-07	3.9e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.89e-07	3.9e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK3—hematologic cancer	7.82e-07	3.87e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.69e-07	3.8e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAP2K1—hematologic cancer	7.65e-07	3.79e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—hematologic cancer	7.61e-07	3.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CD—hematologic cancer	7.6e-07	3.76e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	7.6e-07	3.76e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—hematologic cancer	7.59e-07	3.75e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTP1—hematologic cancer	7.52e-07	3.72e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NUP98—hematologic cancer	7.44e-07	3.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF2—hematologic cancer	7.28e-07	3.6e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—hematologic cancer	7.24e-07	3.58e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.23e-07	3.58e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.23e-07	3.58e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3R1—hematologic cancer	7.18e-07	3.55e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NUP214—hematologic cancer	7.18e-07	3.55e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—hematologic cancer	7.18e-07	3.55e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.03e-07	3.48e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTR—hematologic cancer	7.03e-07	3.48e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—hematologic cancer	7.03e-07	3.48e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAK2—hematologic cancer	6.98e-07	3.45e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK3—hematologic cancer	6.95e-07	3.44e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—hematologic cancer	6.91e-07	3.42e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOR1—hematologic cancer	6.91e-07	3.42e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ENO2—hematologic cancer	6.89e-07	3.41e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—EP300—hematologic cancer	6.84e-07	3.39e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MDM2—hematologic cancer	6.81e-07	3.37e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—hematologic cancer	6.76e-07	3.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CREBBP—hematologic cancer	6.71e-07	3.32e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.69e-07	3.31e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CB—hematologic cancer	6.63e-07	3.28e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTOR—hematologic cancer	6.63e-07	3.28e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—hematologic cancer	6.61e-07	3.27e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SDC1—hematologic cancer	6.54e-07	3.23e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—hematologic cancer	6.46e-07	3.19e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CD—hematologic cancer	6.37e-07	3.15e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—hematologic cancer	6.28e-07	3.11e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—hematologic cancer	6.25e-07	3.09e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—hematologic cancer	6.22e-07	3.08e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—hematologic cancer	6.11e-07	3.02e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3R1—hematologic cancer	6.01e-07	2.97e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—hematologic cancer	5.97e-07	2.96e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1A—hematologic cancer	5.74e-07	2.84e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—hematologic cancer	5.73e-07	2.83e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—hematologic cancer	5.72e-07	2.83e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NQO1—hematologic cancer	5.56e-07	2.75e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CD44—hematologic cancer	5.56e-07	2.75e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CB—hematologic cancer	5.55e-07	2.75e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EP300—hematologic cancer	5.46e-07	2.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SRC—hematologic cancer	5.31e-07	2.63e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—hematologic cancer	5.27e-07	2.61e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYCS—hematologic cancer	5.26e-07	2.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.23e-07	2.59e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—hematologic cancer	5.13e-07	2.54e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—hematologic cancer	5.12e-07	2.53e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRAS—hematologic cancer	5.11e-07	2.53e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—hematologic cancer	5.06e-07	2.5e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK3—hematologic cancer	4.89e-07	2.42e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—hematologic cancer	4.79e-07	2.37e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CREBBP—hematologic cancer	4.76e-07	2.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—hematologic cancer	4.76e-07	2.35e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—hematologic cancer	4.75e-07	2.35e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—hematologic cancer	4.69e-07	2.32e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.64e-07	2.29e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—EP300—hematologic cancer	4.57e-07	2.26e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CD—hematologic cancer	4.51e-07	2.23e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—hematologic cancer	4.45e-07	2.2e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—hematologic cancer	4.4e-07	2.18e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.39e-07	2.17e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3R1—hematologic cancer	4.26e-07	2.11e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.26e-07	2.11e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.26e-07	2.11e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—hematologic cancer	4.14e-07	2.05e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—hematologic cancer	4.04e-07	2e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.93e-07	1.95e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.76e-07	1.86e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—hematologic cancer	3.74e-07	1.85e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—hematologic cancer	3.58e-07	1.77e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—hematologic cancer	3.4e-07	1.68e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—hematologic cancer	3.38e-07	1.67e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—hematologic cancer	3.3e-07	1.63e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—EP300—hematologic cancer	3.24e-07	1.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.16e-07	1.56e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.93e-07	1.45e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.78e-07	1.38e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—hematologic cancer	2.76e-07	1.37e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—hematologic cancer	2.74e-07	1.36e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.63e-07	1.3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.42e-07	1.2e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—hematologic cancer	2.4e-07	1.19e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—hematologic cancer	2.09e-07	1.04e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—EP300—hematologic cancer	2e-07	9.88e-06	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—hematologic cancer	1.96e-07	9.69e-06	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.48e-07	7.31e-06	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.21e-07	5.97e-06	CbGpPWpGaD
